Christopher C. Nixon
University of California, San Francisco(US)
Publications by Year
Research Areas
HIV Research and Treatment, Immune Cell Function and Interaction, COVID-19 Clinical Research Studies, HIV/AIDS Research and Interventions, SARS-CoV-2 and COVID-19 Research
Most-Cited Works
- → Systemic HIV and SIV latency reversal via non-canonical NF-κB signalling in vivo(2020)313 cited
- → Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptoms(2021)262 cited
- → In Vivo Suppression of HIV Rebound by Didehydro-Cortistatin A, a “Block-and-Lock” Strategy for HIV-1 Treatment(2017)251 cited
- → Characterization and Biomarker Analyses of Post-COVID-19 Complications and Neurological Manifestations(2021)185 cited
- → SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assay(2021)149 cited
- → Antitumor activity from antigen-specific CD8 T cells generated in vivo from genetically engineered human hematopoietic stem cells(2011)104 cited
- → Correction: Corrigendum: Cocaine exposure impairs multilineage hematopoiesis of human hematopoietic progenitor cells mediated by the sigma-1 receptor(2015)104 cited
- → T cells establish and maintain CNS viral infection in HIV-infected humanized mice(2018)64 cited
- → HIV-1 infection of hematopoietic progenitor cells in vivo in humanized mice(2013)49 cited
- → First-in-human immunoPET imaging of HIV-1 infection using 89Zr-labeled VRC01 broadly neutralizing antibody(2022)46 cited